VIROMED MEDICAL NA O.N. Defensive Interval Ratio

Latest as of December 2025: 197 days

VIROMED MEDICAL NA O.N. defensive interval ratio. VIROMED MEDICAL NA O.N. (VME) has a Defensive Interval Ratio of 197 days as of December 2025. Defensive assets of €1.12 Million (cash €-, short-term investments €4.51K, receivables €1.12 Million) cover 197 days of daily cash needs of €5.68K/day. See how liquid is VIROMED MEDICAL NA O.N.'s working capital to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

197 days
Days of operational coverage

Defensive Assets

€1.12 Million
Cash + ST Investments + Receivables

Daily Cash Need

€5.68K
Current Liabilities ÷ 365

Current Liabilities

€2.07 Million
EUR

Defensive Interval Ratio of VIROMED MEDICAL NA O.N. (2024–2025)

Defensive interval ratio of VIROMED MEDICAL NA O.N. from 2024 to 2025. This chart shows how VIROMED MEDICAL NA O.N.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 197 days, meaning defensive assets of €1.12 Million can fund 197 days of operations without new revenue. Check VME cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

VIROMED MEDICAL NA O.N. Defensive Interval Ratio by Year (2024–2025)

VIROMED MEDICAL NA O.N. defensive interval ratio by year from 2024 to 2025. The table below presents the year-by-year Defensive Interval Ratio for VIROMED MEDICAL NA O.N. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see VME total asset value.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 197 days €1.12 Million €5.68K/day €- €4.51K ▲ +178 days
2024 19 days €148.12K €7.82K/day €- €3.78K —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)